Site: 001-058 — New Haven, Connecticut

Site: 001-058 is a clinical research site located in New Haven, Connecticut, United States 06511.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site: 001-058 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced or Metastatic Solid Tumors.

Sponsors: Day One Biopharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New Haven

Browse all research sites in Connecticut · View every site in New Haven

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site: 001-058?

Site: 001-058 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site: 001-058 conducted?

Site: 001-058 has 1 clinical trials on record, with 1 currently active. Their work covers Advanced or Metastatic Solid Tumors.

Is Site: 001-058 accredited by Crixeo Clinical Trials?

Site: 001-058 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site: 001-058?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.